\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ is\\ normal\\ except\\ for\\ mild\\ tenderness\\ to\\ palpation\\ over\\ the\\ left\\ posterior\\ ribs\\.\ \(0\)\
\-\ current\\ treatment\\ for\\ multiple\\ myeloma\\ is\\ initial\\ combination\\ chemotherapy\\ and\\ other\\ medication\\ such\\ as\\ steroids\\ or\\ thalidomide\\ for\\ cytoreduction\\ followed\\ by\\ bone\\ marrow\\ transplantation\\ \\(3\\)\\.\\ recent\\ studies\\ have\\ shown\\ the\\ bisphosphonates\\ decrease\\ the\\ incidence\\ of\\ pathologic\\ fractures\\.\\ patients\\ are\\ followed\\ with\\ skeletal\\ surveys\\ to\\ evaluate\\ for\\ response\\ to\\ therapy\\ and\\ disease\\ progression\\.\\ \\ bone\\ scans\\ are\\ usually\\ negative\\ with\\ multiple\\ myeloma\\.\\ ct\\ and\\ mri\\ can\\ be\\ used\\ to\\ define\\ the\\ lesions\\ more\\ accurately\\.\\ the\\ new\\ technique\\ of\\ total\\ body\\ mri\\ may\\ become\\ useful\\ for\\ evaluating\\ the\\ extent\\ of\\ disease\\ on\\ one\\ study\\(4\\)\\.\ \(0\)\
\-\ 1\\.\\ \\ a\\-p\\ radiograph\\ of\\ the\\ lower\\ ribs\\ shows\\ an\\ expansile\\ lytic\\ lesion\\ of\\ the\\ left\\ tenth\\ rib\\.\ \(0\)\
\-\ 2\\.\\ a\\-p\\ radiograph\\ of\\ the\\ pelvis\\ shows\\ lytic\\ lesions\\ of\\ both\\ acetabular\\ regions\\.\ \(0\)\
\-\ 3\\.\\ \\ lateral\\ radiograph\\ of\\ the\\ skull\\ shows\\ lytic\\ lesions\\ \\ in\\ the\\ temporoparietal\\ region\\.\ \(0\)\
\-\ multiple\\ myeloma\ \(25\)\
\-\ metastatic\\ disease\\,multiple\\ myeloma\ \(0\)\
\-\ 55\\ y\\/o\\ african\\-american\\ female\\ \\ presents\\ with\\ left\\ hip\\ and\\ rib\\ pain\\ on\\ follow\\-up\\ visit\\ for\\ known\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ myeloma\\:\\ 0\\.37487618781746274\ \(0\)\
\-\ lytic\\:\\ 0\\.2280560309675119\ \(0\)\
\-\ the\\:\\ 0\\.19808233283855564\ \(0\)\
\-\ ribs\\:\\ 0\\.17706964450680904\ \(0\)\
\-\ multiple\\:\\ 0\\.17656648171533476\ \(0\)\
\-\ radiograph\\:\\ 0\\.17633755036218177\ \(0\)\
\-\ rib\\:\\ 0\\.1648667894922437\ \(0\)\
\-\ for\\:\\ 0\\.16411847556330422\ \(0\)\
\-\ shows\\:\\ 0\\.1589010002381113\ \(0\)\
\-\ lesions\\:\\ 0\\.15548909416948298\ \(0\)\
\-\ disease\\:\\ 0\\.15152941844785037\ \(0\)\
\-\ of\\:\\ 0\\.1412870229596305\ \(0\)\
\-\ thalidomide\\:\\ 0\\.1379093870322829\ \(0\)\
\-\ cytoreduction\\:\\ 0\\.1379093870322829\ \(0\)\
\-\ surveys\\:\\ 0\\.1379093870322829\ \(0\)\
\-\ tenth\\:\\ 0\\.12982779842218914\ \(0\)\
\-\ temporoparietal\\:\\ 0\\.12694335459594214\ \(0\)\
\-\ followed\\:\\ 0\\.12188498331260063\ \(0\)\
\-\ bisphosphonates\\:\\ 0\\.11597732215960135\ \(0\)\
\-\ accurately\\:\\ 0\\.1114260074802118\ \(0\)\
\-\ transplantation\\:\\ 0\\.10501128972326058\ \(0\)\
\-\ define\\:\\ 0\\.10501128972326058\ \(0\)\
\-\ acetabular\\:\\ 0\\.10314788664569895\ \(0\)\
\-\ bone\\:\\ 0\\.098482814234081\ \(0\)\
\-\ technique\\:\\ 0\\.09308613693279408\ \(0\)\
\-\ visit\\:\\ 0\\.09308613693279408\ \(0\)\
\-\ mri\\:\\ 0\\.09264928655659678\ \(0\)\
\-\ left\\:\\ 0\\.09235534317819005\ \(0\)\
\-\ evaluating\\:\\ 0\\.09078088273485835\ \(0\)\
\-\ to\\:\\ 0\\.09024598136220123\ \(0\)\
\-\ useful\\:\\ 0\\.08616267306948429\ \(0\)\
\-\ except\\:\\ 0\\.08410026559926441\ \(0\)\
\-\ combination\\:\\ 0\\.08375254521497504\ \(0\)\
\-\ medication\\:\\ 0\\.0834123032712003\ \(0\)\
\-\ response\\:\\ 0\\.08324488752254237\ \(0\)\
\-\ progression\\:\\ 0\\.08275301451802491\ \(0\)\
\-\ extent\\:\\ 0\\.08259239749771145\ \(0\)\
\-\ skeletal\\:\\ 0\\.08181289793869365\ \(0\)\
\-\ expansile\\:\\ 0\\.08166150309329255\ \(0\)\
\-\ become\\:\\ 0\\.08008529518519737\ \(0\)\
\-\ steroids\\:\\ 0\\.0792874467741022\ \(0\)\
\-\ current\\:\\ 0\\.0790301949171911\ \(0\)\
\-\ scans\\:\\ 0\\.0785279101711895\ \(0\)\
\-\ incidence\\:\\ 0\\.0776855478423132\ \(0\)\
\-\ decrease\\:\\ 0\\.07756878981706375\ \(0\)\
\-\ 55\\:\\ 0\\.07756878981706375\ \(0\)\
\-\ regions\\:\\ 0\\.07745288716964231\ \(0\)\
\-\ marrow\\:\\ 0\\.07499763624048528\ \(0\)\
\-\ and\\:\\ 0\\.0745934947801992\ \(0\)\
\-\ pathologic\\:\\ 0\\.07394572593934416\ \(0\)\
\-\ total\\:\\ 0\\.07394572593934416\ \(0\)\
\-\ skull\\:\\ 0\\.07322237066449623\ \(0\)\
\-\ evaluate\\:\\ 0\\.07017671465426804\ \(0\)\
\-\ shown\\:\\ 0\\.06995949420822814\ \(0\)\
\-\ hip\\:\\ 0\\.06932517421021836\ \(0\)\
\-\ are\\:\\ 0\\.06848902926042946\ \(0\)\
\-\ used\\:\\ 0\\.06756187773484873\ \(0\)\
\-\ fractures\\:\\ 0\\.06671951540597243\ \(0\)\
\-\ studies\\:\\ 0\\.06620075940328868\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.06408112071659947\ \(0\)\
\-\ pelvis\\:\\ 0\\.06311908330878901\ \(0\)\
\-\ new\\:\\ 0\\.0624341001052256\ \(0\)\
\-\ recent\\:\\ 0\\.06110601394530508\ \(0\)\
\-\ palpation\\:\\ 0\\.060861359988167746\ \(0\)\
\-\ initial\\:\\ 0\\.06054093099703155\ \(0\)\
\-\ study\\:\\ 0\\.06018803962377177\ \(0\)\
\-\ body\\:\\ 0\\.05939400571314453\ \(0\)\
\-\ known\\:\\ 0\\.05842837882361384\ \(0\)\
\-\ such\\:\\ 0\\.058051270943843825\ \(0\)\
\-\ usually\\:\\ 0\\.05681363533431638\ \(0\)\
\-\ tenderness\\:\\ 0\\.056595845298507946\ \(0\)\
\-\ negative\\:\\ 0\\.05587110909225651\ \(0\)\
\-\ on\\:\\ 0\\.05451209915029212\ \(0\)\
\-\ region\\:\\ 0\\.05398149119409177\ \(0\)\
\-\ with\\:\\ 0\\.05301429072081826\ \(0\)\
\-\ therapy\\:\\ 0\\.05185257678877383\ \(0\)\
\-\ one\\:\\ 0\\.051670466684582396\ \(0\)\
\-\ mild\\:\\ 0\\.05115828298994061\ \(0\)\
\-\ patients\\:\\ 0\\.05076869896641594\ \(0\)\
\-\ both\\:\\ 0\\.05032598726428449\ \(0\)\
\-\ over\\:\\ 0\\.05018112754155674\ \(0\)\
\-\ more\\:\\ 0\\.04955508560805225\ \(0\)\
\-\ metastatic\\:\\ 0\\.04949579519282114\ \(0\)\
\-\ is\\:\\ 0\\.04942933863207508\ \(0\)\
\-\ physical\\:\\ 0\\.04893382725928168\ \(0\)\
\-\ can\\:\\ 0\\.04735860410986935\ \(0\)\
\-\ other\\:\\ 0\\.04686655525109142\ \(0\)\
\-\ posterior\\:\\ 0\\.046667342034037704\ \(0\)\
\-\ lower\\:\\ 0\\.04611615741476575\ \(0\)\
\-\ exam\\:\\ 0\\.045430229110954144\ \(0\)\
\-\ may\\:\\ 0\\.04541498029954312\ \(0\)\
\-\ have\\:\\ 0\\.04508317205198778\ \(0\)\
\-\ lateral\\:\\ 0\\.04478745053329088\ \(0\)\
\-\ female\\:\\ 0\\.043548190592274834\ \(0\)\
\-\ presents\\:\\ 0\\.04341331645388512\ \(0\)\
\-\ lesion\\:\\ 0\\.04326627099585449\ \(0\)\
\-\ treatment\\:\\ 0\\.04298928730328945\ \(0\)\
\-\ by\\:\\ 0\\.03832397883755873\ \(0\)\
\-\ normal\\:\\ 0\\.03684711858137904\ \(0\)\
\-\ be\\:\\ 0\\.036609474448779857\ \(0\)\
\-\ as\\:\\ 0\\.03625529844253324\ \(0\)\
\-\ an\\:\\ 0\\.03451003149358008\ \(0\)\
\-\ ct\\:\\ 0\\.034357762362272636\ \(0\)\
\-\ pain\\:\\ 0\\.032293587039292075\ \(0\)\
\-\ or\\:\\ 0\\.03139521664016066\ \(0\)\
\-\ in\\:\\ 0\\.02245044770721058\ \(0\)\
